$DORM
Dorman Products, Inc.

2015 Q4 Form 10-Q Financial Statement

#000119312515357363 Filed on October 29, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $204.8M $210.9M $197.8M
YoY Change 17.73% 6.64% 11.15%
Cost Of Revenue $127.0M $130.1M $121.9M
YoY Change 18.36% 6.74% 12.62%
Gross Profit $77.80M $80.79M $75.88M
YoY Change 16.64% 6.47% 8.86%
Gross Profit Margin 37.98% 38.3% 38.36%
Selling, General & Admin $43.40M $39.55M $37.41M
YoY Change 13.91% 5.75% 9.9%
% of Gross Profit 55.78% 48.96% 49.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.500M $4.100M $3.200M
YoY Change 21.62% 28.12% 18.52%
% of Gross Profit 5.78% 5.07% 4.22%
Operating Expenses $43.50M $39.55M $37.41M
YoY Change 14.17% 5.75% 9.9%
Operating Profit $34.37M $41.24M $38.48M
YoY Change 20.13% 7.18% 7.87%
Interest Expense -$100.0K $48.00K $58.00K
YoY Change -17.24% 23.4%
% of Operating Profit -0.29% 0.12% 0.15%
Other Income/Expense, Net
YoY Change
Pretax Income $34.30M $41.19M $38.42M
YoY Change 19.93% 7.22% 7.85%
Income Tax $12.50M $15.13M $13.88M
% Of Pretax Income 36.44% 36.74% 36.13%
Net Earnings $21.79M $26.06M $24.54M
YoY Change 16.78% 6.21% 7.2%
Net Earnings / Revenue 10.64% 12.35% 12.4%
Basic Earnings Per Share $0.73 $0.68
Diluted Earnings Per Share $0.62 $0.73 $0.68
COMMON SHARES
Basic Shares Outstanding 35.50M shares 35.51M shares 35.90M shares
Diluted Shares Outstanding 35.58M shares 36.02M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.70M $79.30M $44.20M
YoY Change 64.99% 79.41% -8.49%
Cash & Equivalents $78.66M $79.32M $44.21M
Short-Term Investments
Other Short-Term Assets $2.300M $29.90M $24.70M
YoY Change -25.81% 21.05% 7.86%
Inventory $193.7M $195.3M $180.2M
Prepaid Expenses
Receivables $203.9M $199.3M $189.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $478.6M $503.8M $438.3M
YoY Change 11.22% 14.95% 9.83%
LONG-TERM ASSETS
Property, Plant & Equipment $87.05M $86.31M $80.97M
YoY Change 5.81% 6.59% 37.9%
Goodwill $28.15M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.74M $19.30M $2.935M
YoY Change 48.2% 557.48% 69.26%
Total Long-Term Assets $143.2M $135.5M $113.9M
YoY Change 12.47% 18.96% 25.79%
TOTAL ASSETS
Total Short-Term Assets $478.6M $503.8M $438.3M
Total Long-Term Assets $143.2M $135.5M $113.9M
Total Assets $621.9M $639.3M $552.2M
YoY Change 11.5% 15.78% 12.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.97M $58.98M $53.96M
YoY Change 7.43% 9.32% 9.81%
Accrued Expenses $23.63M $19.20M $19.43M
YoY Change 14.84% -1.18% -5.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $98.57M $87.03M $82.30M
YoY Change 8.52% 5.74% 5.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.259M $4.706M $5.694M
YoY Change 9.06% -17.35% -1.47%
Total Long-Term Liabilities $5.259M $4.706M $5.694M
YoY Change 9.06% -17.35% -1.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $98.57M $87.03M $82.30M
Total Long-Term Liabilities $5.259M $4.706M $5.694M
Total Liabilities $103.8M $91.74M $88.00M
YoY Change 8.55% 4.25% 5.3%
SHAREHOLDERS EQUITY
Retained Earnings $474.9M $481.9M $401.7M
YoY Change 13.53% 19.97% 14.69%
Common Stock $43.15M $44.12M $356.0K
YoY Change -1.42% 12293.26% -2.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $518.0M $526.1M $445.7M
YoY Change
Total Liabilities & Shareholders Equity $621.9M $639.3M $552.2M
YoY Change 11.5% 15.78% 12.78%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $21.79M $26.06M $24.54M
YoY Change 16.78% 6.21% 7.2%
Depreciation, Depletion And Amortization $4.500M $4.100M $3.200M
YoY Change 21.62% 28.12% 18.52%
Cash From Operating Activities $34.60M $22.60M $28.20M
YoY Change 183.61% -19.86% 81.94%
INVESTING ACTIVITIES
Capital Expenditures -$5.200M -$5.500M -$7.100M
YoY Change -24.64% -22.54% 22.41%
Acquisitions
YoY Change
Other Investing Activities -$100.0K $0.00
YoY Change
Cash From Investing Activities -$5.300M -$5.500M -$7.100M
YoY Change -23.19% -22.54% 22.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.90M -5.000M -30.90M
YoY Change 1473.68% -83.82% 2709.09%
NET CHANGE
Cash From Operating Activities 34.60M 22.60M 28.20M
Cash From Investing Activities -5.300M -5.500M -7.100M
Cash From Financing Activities -29.90M -5.000M -30.90M
Net Change In Cash -600.0K 12.10M -9.800M
YoY Change -117.65% -223.47% -213.95%
FREE CASH FLOW
Cash From Operating Activities $34.60M $22.60M $28.20M
Capital Expenditures -$5.200M -$5.500M -$7.100M
Free Cash Flow $39.80M $28.10M $35.30M
YoY Change 108.38% -20.4% 65.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60593000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.28
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
72900 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
27.82
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35611238 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35611238 shares
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
43413000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10713000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
462061000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4822000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
59541000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20579000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
418292000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
580368000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
356000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
90833000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
22652000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12645000
CY2014Q4 us-gaap Assets
Assets
580368000
CY2014Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
65603000
CY2014Q4 us-gaap Inventory Net
InventoryNet
173523000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206035000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82270000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
105117000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
455464000
CY2014Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29989000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3147000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2014Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
2803000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
25103000
CY2014Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
79179000
CY2014Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
298900000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44210000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.99
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81170 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
37.92
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35523278 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
42000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35523278 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.45
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
43765000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8847000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
526069000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4706000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1600000
CY2015Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1100000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
58983000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19199000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
481949000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
639305000
CY2015Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
355000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
87029000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
21501000
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1793710
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19297000
CY2015Q3 us-gaap Assets
Assets
639305000
CY2015Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
75548000
CY2015Q3 us-gaap Inventory Net
InventoryNet
195250000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
199257000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86308000
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
116863000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
503786000
CY2015Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29914000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3544000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79321000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1855300
CY2015Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
2839000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
26414000
CY2015Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
85569000
CY2015Q3 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
339900000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35497578 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
47406000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36372000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
155000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36217000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.97
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22992000
us-gaap Net Income Loss
NetIncomeLoss
71331000
us-gaap Sales Revenue Net
SalesRevenueNet
577495000
us-gaap Interest Paid
InterestPaid
176000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
797000
us-gaap Operating Income Loss
OperatingIncomeLoss
112123000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12051000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4764000
us-gaap Gross Profit
GrossProfit
220484000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8662000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111963000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38192000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-5000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40632000
us-gaap Share Based Compensation
ShareBasedCompensation
1510000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16383000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9001000
us-gaap Interest Expense
InterestExpense
160000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22992000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-40797000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-434000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1221000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
463000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-9168000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
380200000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108361000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
357011000
us-gaap Restricted Stock Expense
RestrictedStockExpense
1500000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
219000
dorm Other Stock Related Activity
OtherStockRelatedActivity
81000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
41341000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
57483000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
44104 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000868780
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
3674 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7M6D
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
32160 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-26
dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35611000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
76000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.16
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.26
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35535000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
42.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.68
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31000 shares
dei Trading Symbol
TradingSymbol
DORM
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11739000
us-gaap Interest Expense
InterestExpense
152000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18534000
us-gaap Net Income Loss
NetIncomeLoss
70542000
us-gaap Sales Revenue Net
SalesRevenueNet
598123000
us-gaap Interest Paid
InterestPaid
211000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
397000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-7284000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2462000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3467000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
377000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16534000
us-gaap Operating Income Loss
OperatingIncomeLoss
111787000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21727000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4652000
us-gaap Gross Profit
GrossProfit
230257000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6693000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111635000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41709000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-5400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41093000
us-gaap Share Based Compensation
ShareBasedCompensation
752000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31665000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
391900000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118470000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
367866000
us-gaap Restricted Stock Expense
RestrictedStockExpense
700000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000
dorm Other Stock Related Activity
OtherStockRelatedActivity
34000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36024000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
126000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35898000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15132000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
7334000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
24536000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
197796000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38476000
CY2014Q3 us-gaap Gross Profit
GrossProfit
75881000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38418000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13882000
CY2014Q3 us-gaap Interest Expense
InterestExpense
58000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37405000
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
121915000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35575000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
61000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35514000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
26060000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
210928000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41240000
CY2015Q3 us-gaap Gross Profit
GrossProfit
80794000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41192000
CY2015Q3 us-gaap Interest Expense
InterestExpense
48000
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39554000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
130134000

Files In Submission

Name View Source Status
0001193125-15-357363-index-headers.html Edgar Link pending
0001193125-15-357363-index.html Edgar Link pending
0001193125-15-357363.txt Edgar Link pending
0001193125-15-357363-xbrl.zip Edgar Link pending
d28957d10q.htm Edgar Link pending
d28957dex311.htm Edgar Link pending
d28957dex312.htm Edgar Link pending
d28957dex32.htm Edgar Link pending
dorm-20150926.xml Edgar Link completed
dorm-20150926.xsd Edgar Link pending
dorm-20150926_cal.xml Edgar Link unprocessable
dorm-20150926_def.xml Edgar Link unprocessable
dorm-20150926_lab.xml Edgar Link unprocessable
dorm-20150926_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending